Last reviewed · How we verify

NCT05041075

Effect of Weighted Blankets on Anxiety for Pediatric Oncology Patients

Completed NA Last updated 15 June 2025
What this trial tests

NA trial testing Weighted Blanket in Pediatric Cancer in 26 participants. Completed in 25 July 2023.

Timeline
10 January 2022
Primary endpoint
25 July 2023
25 July 2023

Quick facts

Lead sponsorUniversity of Colorado, Denver
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposesupportive care
Enrollment26
Start date10 January 2022
Primary completion25 July 2023
Estimated completion25 July 2023
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Colorado, Denver

Who can join

Adults 4 to 17, any sex, with Pediatric Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The use of weighted blankets has been studied in the adult population but there is a lack of evidence to determine their benefit among a pediatric population, specifically oncology pediatric patients. Pediatric oncology patients routinely experience anxiety during therapy and as cure rates increase, attention has progressively turned to treating psychosocial aspects of care.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Weighted Blanket

Trials testing the same drug.

Other recruiting trials for Pediatric Cancer

Currently open trials in the same condition.

Other University of Colorado, Denver trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05041075.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing